RYE BROOK

MeritB2B Announces Promotion of Karie Burt to Chief Data and Privacy Officer

Retrieved on: 
Wednesday, June 2, 2021
Articles, Digital rights, Human rights, Terms of service, Identity management, Privacy law, Business, Chief privacy officer, Privacy Office of the U.S. Department of Homeland Security, Internet privacy, Privacy

RYE BROOK, N.Y., June 02, 2021 (GLOBE NEWSWIRE) -- MeritB2B, the leading provider of B2B data and performance marketing solutions, today announced the promotion of Karie Burt to Chief Data and Privacy Officer.

Key Points: 
  • RYE BROOK, N.Y., June 02, 2021 (GLOBE NEWSWIRE) -- MeritB2B, the leading provider of B2B data and performance marketing solutions, today announced the promotion of Karie Burt to Chief Data and Privacy Officer.
  • Formerly Senior Vice President and Chief Privacy Officer, Burt joined the company in 2013 and has been a valuable resource on international data availability and opportunities, as well as the data and privacy leader for the company.
  • In her new role as Chief Data and Privacy Officer, Burt will be leading MeritB2Bs data-centric charge; aligning data acquisition, data strategy and operations into a singular group to support MeritB2B products, facilitated by her solid B2B leadership experience.
  • Im thrilled to promote Karie to Chief Data and Privacy Officer, as shes been at the forefront of innovation and data best practices throughout her tenure at MeritB2B, said Rob Sanchez, CEO and Founder of MeritB2B.

Subaru of America Dedicates June To Sharing Hope And Warmth With Those Battling Cancer

Retrieved on: 
Wednesday, June 2, 2021
Subaru

Visitors to participating Subaru retailers will be given the opportunity to write personalized messages of support to cancer patients in their local communities.

Key Points: 
  • Visitors to participating Subaru retailers will be given the opportunity to write personalized messages of support to cancer patients in their local communities.
  • Since 2016, Subaru and its retailers have partnered with LLS to provide love and hope to patients going through challengingcancer treatments.
  • Subaru is proud to have donated over 167,000warm blankets along with thousands of hand-written notes of encouragement to thesepatients across the nation.
  • Subaru Loves to Care is part of the Subaru Love Promise commitment to show love and respect to all people at every interaction with Subaru.

The Center for International Blood and Marrow Transplant Research (CIBMTR) Launches Study of COVID-19 Vaccine Immunogenicity in Patients With Hematological Malignancies Who Have Received Cellular Therapy

Retrieved on: 
Tuesday, May 18, 2021
Research, General Health, Pharmaceutical, Infectious diseases, University, Education, Surgery, Clinical trials, Science, Cardiology, Biotechnology, Stem cells, Health, Cancer

HCT and CAR-T cell therapies are used primarily in patients with blood cancers and other life-threatening blood diseases.

Key Points: 
  • HCT and CAR-T cell therapies are used primarily in patients with blood cancers and other life-threatening blood diseases.
  • Patients who meet the protocol\xe2\x80\x99s eligibility criteria and who consent to the collection of four blood samples will be enrolled.
  • A major national research center, MCW is the largest research institution in the Milwaukee metro area and second largest in Wisconsin.
  • Patients should contact the LLS Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m., ET.

MeritB2B Delivers Data-Driven B2B Digital Transformation For Infinite Electronics

Retrieved on: 
Monday, May 3, 2021
Personal selling, Sales, Upselling

\xe2\x80\x9cIn partnership with MeritB2B, we have implemented data-driven strategies designed to capture net-new logos, achieve a more holistic view of campaign performance, and create new insight-led processes for informed decision-making.

Key Points: 
  • \xe2\x80\x9cIn partnership with MeritB2B, we have implemented data-driven strategies designed to capture net-new logos, achieve a more holistic view of campaign performance, and create new insight-led processes for informed decision-making.
  • We\xe2\x80\x99re seeing tremendous ROI improvements as a result.\xe2\x80\x9d\nMeritB2B created a custom integration that allows Infinite Electronics to deploy best-in-class analytics and database cleansing without having to adjust their existing tech stack.
  • Infinite Electronics now has:\nWith MeritB2B, Infinite Electronics gained visibility needed to drive net new customer acquisition, a clear understanding of future value of newly acquired customers, and analysis of customer overlap between brands to identify upsell and cross sell opportunities.
  • Infinite Electronics has benefited from:\n\xe2\x80\x9cInfinite Electronics is along the path to become truly data-first in their marketing approach.

The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) Announces Five New Investments Supporting Next Generation Cell Therapies and a Novel Immune Checkpoint Inhibitor

Retrieved on: 
Thursday, April 22, 2021
Branches of biology, Medical specialties, Clinical medicine, Immune system, Cancer immunotherapy, Cell biology, Immunotherapy, Virotherapy, T cell, Checkpoint inhibitor, Molecular oncology

LLS TAP due diligence and investment credibility can help companies raise needed funds to drive clinical-focused research forward.

Key Points: 
  • LLS TAP due diligence and investment credibility can help companies raise needed funds to drive clinical-focused research forward.
  • Off-the-shelf CAR T-cell therapies use healthy donor T cells instead of reengineering a patient\'s own cells.
  • The company\'s Artificial Immune Modulation, or AIM platform, does not rely on genetic manipulation of T cells.
  • Checkpoint inhibitors work by \'releasing the brake\' from the body\'s own immune cells so that they can effectively attack cancer cells.

Thousands Nationwide Reimagine Iconic Stair Climb to Take Down Cancer

Retrieved on: 
Wednesday, April 21, 2021
Leukemia, Medical specialties, Leukemia & Lymphoma Society, Pediatric cancers, Branches of biology, LLS, Tumors of the hematopoietic and lymphoid tissues, Acute myeloid leukemia, Lymphoma, Medicine

b'RYE BROOK, N.Y., April 21, 2021 /PRNewswire/ -- Thousands across the nation are stepping up to help defeat an adversary that has long plagued Americans cancer.

Key Points: 
  • b'RYE BROOK, N.Y., April 21, 2021 /PRNewswire/ -- Thousands across the nation are stepping up to help defeat an adversary that has long plagued Americans cancer.
  • Twenty-one-year-old Big Climb Honored Hero of LLS\'s New Jersey Region, MollyGorczyca, was diagnosed with an aggressive form of blood cancer called acute myeloid leukemia when she was a college sophomore.
  • "\nAll of LLS\'s signature fundraisers have helped LLS invest more than $1.3 billion in cutting-edge blood cancer research worldwide, leading to breakthroughs in treatment.
  • To learn more, visit www.lls.org/big-climb .\nThe Leukemia & Lymphoma Society (LLS) is a global leader in the fight against cancer.

Integrated Medical Communications Launches New Quarterly Print Publication

Retrieved on: 
Monday, April 19, 2021
IMC

"More than ever, we need this type of publication to share updates on the research advances in the field, which are coming at a rapid pace.

Key Points: 
  • "More than ever, we need this type of publication to share updates on the research advances in the field, which are coming at a rapid pace.
  • Experts also discuss the latest developments in blood cancers, new and emerging treatment options, side effects management, and survivorship.
  • "\nIntegrated Medical Communications (IMC) is a recently founded medical publishing company aimed at providing the latest in healthcare news and published literature to healthcare professional across multiple specialties.IMC promotes excellence through providing news that is fair, balanced, and accurate.
  • IMC collaborates with societies, organizations, thought leaders and experts to develop high level content in both digital and print platforms.

Everyday Heroes Fight for a Cancer-Free Future

Retrieved on: 
Thursday, April 15, 2021

But, TheLeukemia&LymphomaSociety (LLS), the global leader in the fight against blood cancer, is making game-changing progress in changing this statistic.

Key Points: 
  • But, TheLeukemia&LymphomaSociety (LLS), the global leader in the fight against blood cancer, is making game-changing progress in changing this statistic.
  • No matter where you\'re from or what you believe in, we all know somebody who has been impacted by the devastation of cancer.
  • "And that wouldn\'t be possible without the everyday heroes involved in campaigns like Man & Woman of the Year.
  • Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m., ET.\n'

MeritB2B Survey Report Shows Digital Growth For B2B Marketers

Retrieved on: 
Wednesday, April 7, 2021
Marketing, Business process, Digital marketing, Online advertising, Business marketing

RYE BROOK, N.Y., April 07, 2021 (GLOBE NEWSWIRE) -- MeritB2B, the leading provider of B2B data and performance marketing solutions, today announced the results of a survey of B2B marketers that shows a dramatic increase in digital marketing over the course of 2020 and a focus on digital growth in 2021.

Key Points: 
  • RYE BROOK, N.Y., April 07, 2021 (GLOBE NEWSWIRE) -- MeritB2B, the leading provider of B2B data and performance marketing solutions, today announced the results of a survey of B2B marketers that shows a dramatic increase in digital marketing over the course of 2020 and a focus on digital growth in 2021.
  • This shows the increasing digital sophistication of B2B marketers as they race to engage the business buyer, with 31% shifting existing budget to support new digital spend and 11% getting new budget.
  • B2B marketers investment in digital is delivering value:
    Half of B2B marketers believe that their marketing spend will return to normal in 2021, while half believe that equilibrium will come in 2022.
  • This means that B2B marketers must continue their digital optimization and growth.

ZEISS Awards Science Classroom Outreach Program for Educators (SCOPEs) Grant to K-12 Science Teachers Across the United States

Retrieved on: 
Wednesday, March 17, 2021
Optics, Carl Zeiss AG, MicroScope

WHITE PLAINS, N.Y., March 17, 2021 /PRNewswire-PRWeb/ -- ZEISS has awarded the first two schools in its Science Classroom Outreach Program for Educators (SCOPEs) Grant , a monthly national grant to help support K-12 science teachers facing the challenge of educating students through distance learning.

Key Points: 
  • WHITE PLAINS, N.Y., March 17, 2021 /PRNewswire-PRWeb/ -- ZEISS has awarded the first two schools in its Science Classroom Outreach Program for Educators (SCOPEs) Grant , a monthly national grant to help support K-12 science teachers facing the challenge of educating students through distance learning.
  • To ensure the success of this national program, ZEISS first launched a regional program for schools near the North American corporate office in White Plains, NY.
  • The SCOPEs grant program covers a complete ZEISS classroom microscope package with an optical microscope, digital camera, and software.
  • Recipients can choose from two microscope models, the new ZEISS Primostar 3 or ZEISS Stemi 305 .